What Is Sleep Apnea?
Obstructive sleep apnea (OSA) syndrome is a sleep-related breathing disorder characterized by repetitive episodes of partial or complete upper airway obstruction during sleep. This obstruction causes breathing pauses (apneas) or significant reductions in airflow (hypopneas), leading to oxygen desaturation and microarousals.
Prevalence ranges from 9-38% in the general adult population, and is more common in men, individuals with obesity, and older adults. In Brazil, the EPISONO study (Tufik et al., 2010) identified OSA (AHI greater than or equal to 5) in approximately 32.8% of the adult population of Sao Paulo — reflecting an urban prevalence with a high burden of risk factors (obesity, age). The vast majority of cases remain undiagnosed.
OSA is an independent risk factor for resistant arterial hypertension, coronary artery disease, cardiac arrhythmias, stroke, and cardiovascular mortality. In addition, sleep fragmentation causes excessive daytime sleepiness, cognitive impairment, and increased risk of motor vehicle accidents.
Pathophysiology
The upper airway is a collapsible tube supported by the tonic activity of the pharyngeal dilator muscles, especially the genioglossus. During sleep, there is a physiological reduction in muscle tone. In patients with OSA, anatomical and neuromuscular factors make the airway prone to collapse.
Obstruction generates respiratory effort against the closed airway, increased intrathoracic negative pressure, intermittent hypoxemia, and hypercapnia. The microarousal restores muscle tone and reopens the airway, but fragments sleep architecture. This cycle repeats dozens to hundreds of times per night.
Intermittent Hypoxemia
Repeated cycles of desaturation-reoxygenation generate oxidative stress, systemic inflammation, and endothelial dysfunction — mediators of cardiovascular risk.
Sympathetic Hyperactivation
Microarousals activate the sympathetic nervous system, raising blood pressure, heart rate, and the risk of nocturnal arrhythmias.
Sleep Fragmentation
Repeated microarousals prevent deep and REM sleep, causing daytime sleepiness, cognitive deficit, and metabolic alterations.
Symptoms
OSA symptoms are divided into nocturnal and daytime. Often, it is the bed partner who first notices the loud snoring and breathing pauses. The patient may not be aware of sleep fragmentation, attributing daytime symptoms to other causes.
Symptoms of Obstructive Sleep Apnea
- 01
Loud and habitual snoring
Present in more than 90% of patients. Typically intense, irregular, with pauses followed by gasps or choking sounds.
- 02
Witnessed breathing pauses
Apneas observed by the bed partner. The patient may report waking with a sensation of suffocation or choking.
- 03
Excessive daytime sleepiness
Need to nap during the day, difficulty staying awake in meetings, while reading, or while driving.
- 04
Morning headache
Headache upon waking, generally frontal, caused by hypercapnia and nocturnal cerebral vasodilation.
- 05
Nocturia
Frequent need to urinate during the night, caused by release of atrial natriuretic peptide due to respiratory effort.
- 06
Cognitive impairment
Difficulty with concentration, memory, and attention. Reduced professional and academic performance.
- 07
Mood alterations
Irritability, depression, and anxiety associated with chronic sleep fragmentation and hypoxemia.
Diagnosis
Definitive diagnosis of OSA requires polysomnography (type I in the laboratory or type III at home). The main parameter is the Apnea-Hypopnea Index (AHI), which quantifies the number of obstructive events per hour of sleep.
Screening questionnaires such as the STOP-BANG help identify patients with a high probability of OSA. STOP-BANG scores greater than or equal to 5 have high sensitivity for moderate to severe OSA.
🏥Classification of OSA Severity
- 1.AHI 5-14 events/hour: mild OSA — consider treatment if symptomatic
- 2.AHI 15-29 events/hour: moderate OSA — treatment indicated
- 3.AHI greater than or equal to 30 events/hour: severe OSA — mandatory treatment
- 4.Minimum saturation less than 80%: additional severity indicator with elevated cardiovascular risk
- 5.Elevated microarousal index: correlates with daytime sleepiness and cognitive impairment
POLYSOMNOGRAPHY: LABORATORY VS. HOME
| FEATURE | LABORATORY PSG (TYPE I) | HOME PSG (TYPE III) |
|---|---|---|
| Channels monitored | EEG, EOG, EMG, ECG, airflow, effort, SpO2, position | Airflow, effort, SpO2, position |
| Sleep staging | Yes — identifies stages N1-N3 and REM | No — does not differentiate wake from sleep |
| Detection of other disorders | Periodic limb movements, parasomnias | Does not assess |
| Convenience | Requires a night in the laboratory | Comfort of home |
| Main indication | Suspicion of other sleep disorders | OSA screening in high clinical probability |
Differential Diagnosis
Excessive daytime sleepiness, snoring, and morning fatigue have several causes beyond OSA. Diagnostic differentiation among hypersomnolence, OSA, narcolepsy, and other sleep disorders is performed by the sleep medicine specialist / pulmonologist based on polysomnography; the medical acupuncturist works in coordination with this team as part of multidisciplinary care.
DIAGNÓSTICO DIFERENCIAL
Diagnóstico Diferencial
Obesity Hypoventilation Syndrome
- BMI greater than 30 + daytime hypercapnia (PaCO2 greater than 45 mmHg)
- Hypoxemia even while awake
- Polycythemia and cor pulmonale in advanced cases
- Frequently coexists with OSA
- Elevated daytime PaCO2 indicates ventilatory failure
- Requires BiPAP or AVAPS, not CPAP alone
Testes Diagnósticos
- Daytime arterial blood gas
- Spirometry
- Polysomnography with BiPAP titration
- Echocardiogram (cor pulmonale)
In this syndrome, the priority is noninvasive mechanical ventilation. Acupuncture may assist the weight-loss program as an adjunct to the main treatment.
Central Apnea (vs Obstructive)
- Breathing pauses without thoracic effort (central) vs with effort (obstructive)
- Cheyne-Stokes apnea: crescendo-decrescendo airflow pattern
- Frequently associated with CHF, stroke, or opioid use
- Predominantly central AHI on polysomnography
- New-onset central apnea in a patient on CPAP: complex central apnea syndrome
Testes Diagnósticos
- Laboratory polysomnography (distinguishes central from obstructive)
- Echocardiogram (CHF as cause)
- BNP if CHF is suspected
Central apnea requires treatment of the underlying cause (CHF, opioids, stroke). The medical acupuncturist can contribute to CHF management and post-stroke rehabilitation as part of multiprofessional care.
Insomnia
- Difficulty initiating or maintaining sleep, without prominent snoring
- Daytime tiredness but not classic sleepiness (subtle distinction)
- Polysomnography: prolonged sleep latency, reduced efficiency, no apneas
- Frequently comorbid with OSA (insomnia-OSA complex)
- Resistant insomnia: investigate underdiagnosed OSA as a cause of fragmentation
Testes Diagnósticos
- Polysomnography
- Sleep diary for 2 weeks
- Actigraphy
Medical acupuncture has evidence for relief of insomnia symptoms and can be integrated into the care plan when polysomnography rules out significant OSA, together with sleep hygiene and CBT-I when indicated.
Narcolepsy
- Irresistible daytime sleepiness since childhood or adolescence
- Cataplexy: sudden loss of muscle tone with strong emotion (pathognomonic)
- Sleep paralysis and hypnagogic hallucinations
- Polysomnography + MSLT: REM sleep latency less than 15 min in 2 or more naps
- Severe cataplexy with falls: trauma risk
Testes Diagnósticos
- Polysomnography + multiple sleep latency test (MSLT)
- HLA DQB1*06:02 (genetic marker)
- CSF hypocretin-1 (type 1)
Narcolepsy requires specific pharmacological treatment. Acupuncture can assist in fatigue management and improve sleep quality as an adjunct.
Hypothyroidism with Snoring
- Late-onset snoring in an adult previously without complaints
- Fatigue, weight gain, hoarse voice, dry skin
- Macroglossia and mucopolysaccharide deposition in the airways
- Elevated TSH with reduced free T4
- Severe hypothyroidism can cause OSA that resolves completely with levothyroxine
Testes Diagnósticos
- TSH and free T4
- Polysomnography before and after hypothyroidism treatment
- Anti-TPO antibodies (Hashimoto)
The medical acupuncturist investigates hypothyroidism in all patients with late-onset snoring. Normalization of TSH with levothyroxine may eliminate the need for CPAP.
Obstructive versus Central Apnea
Obstructive sleep apnea (OSA) and central sleep apnea (CSA) share the clinical presentation of breathing pauses during sleep, but differ fundamentally in pathophysiological mechanism and treatment. In OSA, respiratory effort is present (thoracic and abdominal movements are detected during the apnea), but airflow is absent due to mechanical obstruction of the upper airway. In CSA, both effort and airflow are absent — central respiratory drive is temporarily inhibited, with no command to the respiratory musculature. Polysomnography with respiratory effort channels (thoracic and abdominal bands) is the test that makes this distinction. Cheyne-Stokes apnea, a crescendo-decrescendo pattern of tidal volume with interspersed central apneas, is highly suggestive of congestive heart failure as the cause.
CSA treatment is directed at the underlying cause: optimization of CHF with carvedilol, ACE inhibitors, and diuretics; reduction or discontinuation of opioids; transition from CPAP to BiPAP with backup rate (AVAPS) when necessary. Complex central apnea syndrome — emergence of central apneas after CPAP adaptation — is a recognized entity that may require ASV (adaptive servo-ventilation). The medical acupuncturist should request blood gas analysis and an echocardiogram in patients with predominantly central apneas on polysomnography.
Obesity Hypoventilation Syndrome
Obesity hypoventilation syndrome (OHS), formerly called Pickwickian syndrome, is defined by the triad: obesity (BMI above 30 kg/m2), daytime hypercapnia (PaCO2 above 45 mmHg on arterial blood gas while awake), and exclusion of other causes of alveolar hypoventilation. OHS occurs when excess thoracic and abdominal adipose tissue compromises respiratory mechanics to the point that CO2 is not adequately eliminated even during wakefulness — distinguishing it from simple OSA, where hypercapnia occurs only during sleep. It coexists with OSA in 70-90% of cases. Complications include secondary polycythemia, pulmonary hypertension, and cor pulmonale.
Treatment requires noninvasive ventilation with BiPAP or pressure support ventilation (ASV/AVAPS) to correct hypoventilation, in addition to an intensive weight-loss program — loss of 25-30% of body weight can result in complete resolution. Simple CPAP is insufficient in most OHS cases. Acupuncture can be integrated into the treatment program as support for weight loss, appetite modulation, and reduction of systemic inflammation, but the priority is to ensure adequate ventilation and specialized pulmonology follow-up.
Narcolepsy and Hypersomnia
Narcolepsy type 1 is a central hypersomnia caused by selective loss of hypocretin (orexin)-producing neurons in the lateral hypothalamus, of autoimmune origin. The classic tetrad includes: irresistible daytime sleepiness (EDS), cataplexy (sudden and reversible loss of muscle tone triggered by positive emotions — laughter, surprise — pathognomonic), sleep paralysis, and hypnagogic/hypnopompic hallucinations. Cataplexy clinically distinguishes narcolepsy type 1 from OSA and from idiopathic hypersomnia. Narcolepsy type 2 occurs without cataplexy, with normal or borderline CSF hypocretin-1, and is a more challenging diagnosis. The multiple sleep latency test (MSLT) demonstrates a mean sleep latency below 8 minutes with two or more sleep-onset REM periods.
Idiopathic hypersomnia is another central hypersomnia with excessive daytime sleepiness without cataplexy and an MSLT not conclusive for narcolepsy — a diagnosis of exclusion after OSA, insufficient sleep, and narcolepsy have been ruled out. Pharmacological treatment of narcolepsy includes modafinil, sodium oxybate, and antidepressants for cataplexy. Acupuncture has an adjunctive role in fatigue management and improvement of nocturnal sleep quality and may reduce the symptom burden. The medical acupuncturist should promptly refer to a sleep center any patient with suspected narcolepsy or central hypersomnia.
Treatment
The gold-standard treatment for moderate to severe OSA is CPAP (continuous positive airway pressure). Other options include intraoral devices, positional therapy, surgery, and behavioral measures such as weight loss and sleep hygiene.
Behavioral Measures
Weight loss (a 10% reduction in body weight can decrease the AHI by 26-32%). Avoid alcohol and sedatives before sleep. Smoking cessation. Sleep in lateral decubitus when apnea is position-dependent.
CPAP / BiPAP
Nasal or oronasal CPAP with pressure titrated by polysomnography. Eliminates apneas, normalizes oxygen saturation, and restores sleep architecture. Adherence is the main challenge — 30-50% of patients discontinue.
Intraoral Device
Mandibular advancement device fitted by a sleep dentist. Indicated for mild to moderate OSA or CPAP intolerance. Advances the mandible, increasing the retropharyngeal space.
Surgery and Complementary Therapies
Uvulopalatopharyngoplasty (UPPP), hypoglossal nerve stimulation, and orthognathic surgery in selected cases. Acupuncture as an adjunct to improve pharyngeal muscle tone and sleep quality.
Acupuncture as Treatment
Acupuncture has been investigated as a complementary therapy for OSA, with proposed mechanisms that include possible modulation of the tone of the pharyngeal dilator muscles, modulation of the central chemoreceptor reflex, regulation of the sleep pattern, and reduction of systemic inflammation. The evidence base is still limited and findings should be confirmed in larger studies.
A small Brazilian randomized trial (Freire et al., Sleep Medicine 2007; n=36 with mild to moderate OSA) suggested a reduction in AHI with electroacupuncture compared with sham acupuncture. The evidence is limited to this single study and is not sufficient for recommendation as primary therapy in moderate or severe OSA. Electroacupuncture at cervical and submental points is being investigated as a form of stimulation of the pharyngeal muscles, but the long-term clinical effect is not yet established.
Acupuncture does not replace CPAP in moderate to severe OSA. In mild OSA, it can be considered as part of an integrated plan in patients who do not tolerate or refuse CPAP, always with control polysomnography after the treatment cycle and in coordination with the sleep pulmonologist. It can also assist CPAP adherence by treating symptoms such as nasal congestion and anxiety.
Prognosis
Untreated OSA is a progressive condition with significant cardiovascular consequences. Patients with untreated severe OSA show an increased risk of arterial hypertension, atrial fibrillation, myocardial infarction, stroke, and cardiovascular mortality.
Adequate treatment with CPAP normalizes cardiovascular risk in the majority of adherent patients. Substantial weight loss can significantly reduce or even resolve OSA in patients with obesity. Bariatric surgery, when indicated for other reasons, frequently improves OSA.
Daytime sleepiness, cognitive impairment, and mood alterations improve significantly with adequate treatment, generally within the first weeks of regular CPAP use. Sustained adherence is fundamental for maintenance of the benefits.
Myths and Facts
Myth vs. Fact
Sleep apnea is just louder snoring
OSA is a disease with serious cardiovascular, metabolic, and cognitive consequences. Snoring is a symptom, but the breathing pauses, hypoxemia, and sleep fragmentation cause systemic damage.
Only people with obesity have sleep apnea
Although obesity is the main risk factor, lean people with craniofacial anatomical alterations (retrognathia, micrognathia, hypertrophied tonsils) can have significant OSA.
CPAP is uncomfortable and no one can use it
With the appropriate interface and professional follow-up, the majority of patients adapt to CPAP within 2-4 weeks. Modern interfaces are far more comfortable than older ones.
Surgery cures sleep apnea
Isolated uvulopalatopharyngoplasty (UPPP) has a success rate of only 40-50%. The surgical approach requires careful selection. Orthognathic surgery has better results in selected cases.
When to Seek Help
Suspicion of sleep apnea should be investigated, especially when there is habitual snoring associated with daytime sleepiness, hypertension, or metabolic risk factors.
Frequently Asked Questions about Sleep Apnea
In obstructive apnea (OSA), the airway collapses mechanically but respiratory effort continues — there is movement of the chest and abdomen but no airflow. In central apnea, the brain fails to send the signal to breathe — there is neither effort nor flow. The distinction is diagnosed by complete polysomnography, which measures both airflow and respiratory effort.
The AHI (Apnea-Hypopnea Index) is the number of obstructive events per hour of sleep. AHI 5-14 = mild OSA; AHI 15-29 = moderate OSA; AHI greater than or equal to 30 = severe OSA. Below 5 in adults is considered normal. The AHI should be interpreted together with the minimum oxygen saturation and the daytime sleepiness scale.
CPAP is superior to the intraoral device in AHI reduction and is the gold standard for moderate to severe OSA. The mandibular advancement device is better tolerated long-term by many patients and is effective for mild to moderate OSA. The choice should be individualized by the physician considering severity, anatomy, tolerance, and patient preference. Both are effective if used regularly.
Improvement in daytime sleepiness and mood begins in the first week. Reduction in blood pressure and cardiovascular markers takes weeks to months. For maximum cardiovascular benefit, use of at least 4 hours per night on more than 70% of nights is recommended. Patients who use CPAP for more than 6 hours have the greatest benefits.
Yes. Home polysomnography (type III) is a valid option for OSA screening in patients with high clinical probability (STOP-BANG greater than or equal to 5) and without other sleep disorders. It monitors airflow, respiratory effort, oxygen saturation, and body position. It does not assess sleep staging or detect other disorders (periodic limb movements, parasomnias), for which complete laboratory polysomnography is required.
Habitual snoring in children should always be investigated. The most common cause is hypertrophy of the adenoids and tonsils. Pediatric OSA can cause growth delay, behavioral problems, school difficulty, and, in severe cases, cardiac complications. Pediatric polysomnography has different criteria from the adult — any AHI greater than or equal to 1 in a child is abnormal. Tonsillectomy with adenoidectomy is curative in 80-90% of cases.
No, not for moderate to severe OSA. For mild OSA, the trial by Freire et al. (2007) suggests a possible reduction in AHI with electroacupuncture as an adjunct; the evidence is limited to this small study. For moderate to severe OSA, CPAP remains the first-line treatment — acupuncture does not replace it. Control polysomnography after the acupuncture cycle is essential to confirm any objective reduction.
Yes, very relevant. OSA is one of the main secondary causes of resistant hypertension (elevated BP despite 3 or more medications). Intermittent hypoxemia and nocturnal sympathetic activation chronically raise blood pressure. Adequate treatment of OSA with CPAP can reduce systolic pressure by 2-5 mmHg and, in some cases, allow reduction of antihypertensives.
AHI greater than or equal to 30 events per hour defines severe OSA. However, real severity also depends on the minimum oxygen saturation — desaturations below 80% indicate elevated cardiovascular risk independently of the AHI. The index of time with saturation below 90% (T90) is another important marker of accumulated hypoxemia during sleep.
For mild OSA associated with obesity, substantial weight loss can completely eliminate apnea. Bariatric surgery in patients with morbid obesity cures OSA in 60-80% of cases. Orthognathic surgeries (maxillomandibular advancement) have a success rate of 80-90% in selected anatomical cases. For most patients, CPAP is a long-term treatment — effective while used, but with no disease-modifying effect.
Related Reading
Deepen your knowledge with related articles